X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with FDC LTD. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs FDC LTD. - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES FDC LTD. JUBILANT LIFE SCIENCES/
FDC LTD.
 
P/E (TTM) x 25.9 24.0 107.8% View Chart
P/BV x 5.3 5.0 106.1% View Chart
Dividend Yield % 0.3 0.9 36.2%  

Financials

 JUBILANT LIFE SCIENCES   FDC LTD.
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
FDC LTD.
Mar-14
JUBILANT LIFE SCIENCES/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs187144 130.2%   
Low Rs6579 82.4%   
Sales per share (Unadj.) Rs364.347.6 766.0%  
Earnings per share (Unadj.) Rs6.87.6 90.0%  
Cash flow per share (Unadj.) Rs24.59.0 271.9%  
Dividends per share (Unadj.) Rs3.002.25 133.3%  
Dividend yield (eoy) %2.42.0 117.8%  
Book value per share (Unadj.) Rs164.947.5 346.9%  
Shares outstanding (eoy) m159.28177.83 89.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.32.3 14.8%   
Avg P/E ratio x18.414.6 125.8%  
P/CF ratio (eoy) x5.112.3 41.6%  
Price / Book Value ratio x0.82.3 32.6%  
Dividend payout %43.829.6 148.2%   
Avg Mkt Cap Rs m20,06119,784 101.4%   
No. of employees `0006.2NA-   
Total wages/salary Rs m11,0521,221 905.5%   
Avg. sales/employee Rs Th9,383.0NM-  
Avg. wages/employee Rs Th1,786.9NM-  
Avg. net profit/employee Rs Th176.3NM-  
INCOME DATA
Net Sales Rs m58,0348,459 686.1%  
Other income Rs m191394 48.4%   
Total revenues Rs m58,2248,852 657.7%   
Gross profit Rs m5,7862,070 279.5%  
Depreciation Rs m2,812249 1,128.7%   
Interest Rs m3,23731 10,439.2%   
Profit before tax Rs m-722,184 -3.3%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696606 115.0%   
Profit after tax Rs m1,0901,353 80.6%  
Gross profit margin %10.024.5 40.7%  
Effective tax rate %-965.927.7 -3,482.9%   
Net profit margin %1.916.0 11.7%  
BALANCE SHEET DATA
Current assets Rs m29,2804,355 672.3%   
Current liabilities Rs m38,9121,792 2,171.5%   
Net working cap to sales %-16.630.3 -54.8%  
Current ratio x0.82.4 31.0%  
Inventory Days Days8444 189.8%  
Debtors Days Days5125 205.5%  
Net fixed assets Rs m55,7123,025 1,841.7%   
Share capital Rs m155179 86.5%   
"Free" reserves Rs m20,9688,243 254.4%   
Net worth Rs m26,2658,453 310.7%   
Long term debt Rs m17,16911 160,456.1%   
Total assets Rs m88,60610,557 839.3%  
Interest coverage x1.071.4 1.4%   
Debt to equity ratio x0.70 51,640.2%  
Sales to assets ratio x0.70.8 81.7%   
Return on assets %4.913.1 37.3%  
Return on equity %4.216.0 25.9%  
Return on capital %11.623.5 49.2%  
Exports to sales %37.813.3 284.0%   
Imports to sales %16.53.3 493.1%   
Exports (fob) Rs m21,9331,126 1,948.4%   
Imports (cif) Rs m9,567283 3,383.1%   
Fx inflow Rs m22,0041,146 1,919.9%   
Fx outflow Rs m11,749355 3,306.8%   
Net fx Rs m10,255791 1,296.8%   
CASH FLOW
From Operations Rs m8,0261,485 540.5%  
From Investments Rs m-1,744-620 281.5%  
From Financial Activity Rs m-4,447-753 591.0%  
Net Cashflow Rs m1,834113 1,626.3%  

Share Holding

Indian Promoters % 45.6 68.9 66.2%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 4.7 185.1%  
FIIs % 21.2 7.5 282.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 19.0 111.1%  
Shareholders   23,815 23,730 100.4%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   FRESENIUS KABI ONCO.  AJANTA PHARMA  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare JUBILANT LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jan 19, 2018 03:33 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - ASTRAZENECA PHARMA COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS